UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059304
Receipt number R000067827
Scientific Title Analysis of Local Field Potentials Using SEEG and DBS in Refractory Epilepsy and Movement Disorders
Date of disclosure of the study information 2025/10/06
Last modified on 2025/10/06 13:56:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of Local Field Potentials Using SEEG and DBS in Refractory Epilepsy and Movement Disorders

Acronym

Analysis of Local Field Potentials Using SEEG and DBS in Refractory Epilepsy and Movement Disorders

Scientific Title

Analysis of Local Field Potentials Using SEEG and DBS in Refractory Epilepsy and Movement Disorders

Scientific Title:Acronym

Analysis of Local Field Potentials Using SEEG and DBS in Refractory Epilepsy and Movement Disorders

Region

Japan


Condition

Condition

refractory epilepsy, parkinson's disease, essential tremor, dystonia

Classification by specialty

Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Objective of the Study:
To obtain and analyze local field potential (LFP) data recorded from intracranial electrodes implanted during clinically indicated procedures in patients with drug-resistant epilepsy or neurological disorders accompanied by movement abnormalities, in order to gain new insights.

Basic objectives2

Others

Basic objectives -Others

Objective of the Study:
To obtain and analyze local field potential (LFP) data recorded from intracranial electrodes implanted during clinically indicated procedures in patients with drug-resistant epilepsy or neurological disorders accompanied by movement abnormalities, in order to gain new insights.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Primary Outcome Measures (and Their Indicators / Evaluation Methods):
To examine the relationship between electrophysiological activity at individual electrodes or functional connectivity across multiple brain regions and postoperative outcomes, including seizure control and improvement in motor symptoms. EEG/LFP data obtained from the implanted electrodes will be analyzed offline to assess correlations with clinical data.

Key secondary outcomes

Secondary Outcome Measures (and Their Indicators, Evaluation Methods):
Accuracy of electrode implantation, to be evaluated using patient's medical records and imaging data.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with drug-resistant epilepsy or movement disorders, including Parkinson's disease, essential tremor, or dystonia, who are indicated for intracranial electrode implantation at the Department of Neurosurgery, Keio University School of Medicine.

Patients who provide written informed consent to participate in this study. For minors or adults with insufficient decision-making capacity, written consent will be obtained from their legally authorized representative.

Key exclusion criteria

Patients who develop severe postoperative complications following electrode implantation.

Patients deemed by the principal investigator or co-investigators to be unsuitable for participation in this study for any other reason.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Kenzo
Middle name
Last name Kosugi

Organization

Keio University Hospital

Division name

Department of Neurosurgery

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

TEL

03-3353-1211

Email

kensan03977@keio.jp


Public contact

Name of contact person

1st name Kenzo
Middle name
Last name Kosugi

Organization

Keio University Hospital

Division name

Department of Neurosurgery

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

TEL

03-3353-1211

Homepage URL


Email

kensan03977@keio.jp


Sponsor or person

Institute

Keio University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine Ethics Committee

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

Tel

03-3353-1211

Email

kensan03977@keio.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 10 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 10 Month 29 Day

Date of IRB

2024 Year 10 Month 29 Day

Anticipated trial start date

2024 Year 10 Month 29 Day

Last follow-up date

2034 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2025 Year 10 Month 06 Day

Last modified on

2025 Year 10 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067827